Lila Sciences is a platform that uses artificial intelligence to support research in life sciences, chemical sciences, and materials sciences. It develops AI-driven tools and autonomous labs to improve research efficiency and facilitate scientific discoveries. The platform is designed to enhance various aspects of the scientific method and contribute to advancements in technology and innovation.
Total raised
$550M
Last stage
Series A
Investors
Alexandra Sneider
PhD in Chemical and Biomolecular Engineering from Johns Hopkins University; former Principal at Flagship Pioneering.
Jake Feala
Leads AI-powered autonomous science and computational biology at Lila Sciences.
Geoffrey von Maltzahn
General Partner at Flagship Pioneering; PhD in Biomedical Engineering from MIT; serial biotech founder with 10+ companies achieving over $10B in aggregate market capitalization, including Generate:Biomedicines, Indigo Agriculture, Sana Biotechnology, and Seres Therapeutics.
LinkedInNoubar Afeyan
Founder and CEO of Flagship Pioneering, the bioplatform innovation company that incubated Lila Sciences. Also co-founded Moderna.
Andrew Beam
Appointed as CTO of Lila Sciences at its public launch in March 2025; AI and machine learning expert contributing to the company's scientific AI platform.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.
